批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1987/03/23 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
PRIORITY
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2024/11/21 |
SUPPL-28(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/04/28 |
SUPPL-27(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/07/22 |
SUPPL-26(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/03/10 |
SUPPL-25(补充) |
Approval |
Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2016/05/09 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2016/05/09 |
SUPPL-23(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2016/05/09 |
SUPPL-22(补充) |
Approval |
Labeling-Package Insert,Labeling-Medication Guide |
STANDARD
|
|
|
| 2015/07/30 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2013/03/22 |
SUPPL-20(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2008/07/25 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2007/09/20 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2007/04/19 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/03/10 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/01/24 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2004/11/10 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2004/11/10 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2003/04/14 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/02/22 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2001/01/05 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1996/11/14 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1994/09/12 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 1993/01/27 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:NAPROXEN; 剂型/给药途径:SUSPENSION;ORAL; 规格:25MG/ML; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 018965 |
001 |
NDA |
NAPROSYN |
NAPROXEN |
SUSPENSION;ORAL |
25MG/ML |
Prescription |
Yes |
No |
AB |
1987/03/23
|
ATNAHS PHARMA US |
| 074190 |
001 |
ANDA |
NAPROXEN |
NAPROXEN |
SUSPENSION;ORAL |
25MG/ML |
Prescription |
No |
Yes |
AB |
1994/03/30
|
HIKMA |
| 212705 |
001 |
ANDA |
NAPROXEN |
NAPROXEN |
SUSPENSION;ORAL |
25MG/ML |
Prescription |
No |
No |
AB |
2020/07/31
|
AMNEAL |
| 211910 |
001 |
ANDA |
NAPROXEN |
NAPROXEN |
SUSPENSION;ORAL |
25MG/ML |
Prescription |
No |
No |
AB |
2021/03/10
|
NOVITIUM PHARMA |
| 215776 |
001 |
ANDA |
NAPROXEN |
NAPROXEN |
SUSPENSION;ORAL |
25MG/ML |
Prescription |
No |
No |
AB |
2022/06/07
|
HETERO LABS LTD III |
| 216504 |
001 |
ANDA |
NAPROXEN |
NAPROXEN |
SUSPENSION;ORAL |
25MG/ML |
Prescription |
No |
No |
AB |
2025/10/03
|
AUROBINDO PHARMA |